Summarized by Masters of Longevity from Longevity Technology.
Immorta Bio’s selection for a business accelerator is explained in an article about a startup pursuing anti‑aging therapeutics and commercial growth; readers will learn what type of company and program the piece explores.
Key Takeaways
- Immorta Bio selected for NYU Stern program to advance anti-aging therapies Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.
- Was named to the 2026–27 Life Sciences cohort of Endless Frontier Labs at New York University Stern School of Business after a multi-stage evaluation of the company’s science, development strategy and commercial potential.
- Immorta Bio selected for NYU Stern program to advance anti-aging therapies.
